Ramzi Abi-Akar

Ramzi Abi-Akar

Auto-generated profile, based on publicly available information

Ramzi Abi-Akar

Hôpital européen Georges-Pompidou , Paris, France

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
CCChekrallah Chamandi
Chekrallah Chamandi
RARamzi Abi-Akar
Ramzi Abi-Akar
JRJosep Rodés-Cabau
Josep Rodés-Cabau
DBDidier Blanchard
Didier Blanchard
EDEric Dumont
Eric Dumont
SMSiamak Mohammadi
Siamak Mohammadi
Background: The optimal access for patients undergoing transcatheter aortic valve replacement (TAVR) who are not candidates for a transfemoral approach has not been elucidated. The purpose of this study was to compare the safety, feasibility, and early clinical outcomes of transcarotid TAVR compared with thoracic approaches. Methods and Results: From a multicenter consecutive cohort of 329 alternative-access TAVR patients (2012–2017), we identified 101 patients who underwent transcarotid TAVR and 228 patients who underwent a transapical or transaortic TAVR. Preprocedural success and 30-day clinical outcomes were compared using multivariable propensity score analysis to account for between-group differences in baseline characteristics. All transcarotid cases were performed under general anesthesia, mainly using the left common carotid artery (97%). Propensity-matched groups had similar rates of 30-day all-cause mortality (2.1% versus 4.6%; P =0.37), stroke (2.1% versus 3.5%; P =0.67; transcarotid versus transapical/transaortic, respectively), new pacemaker implantation, and major vascular complications. Transcarotid TAVR was associated with significantly less new-onset atrial fibrillation (3.2% versus 19.0%; P =0.002), major or life-threatening bleeding (4.3% versus 19.9%; P =0.002), acute kidney injury (none versus 12.1%; P =0.002), and shorter median length of hospital stay (6 versus 8 days; P <0.001). Conclusions: Transcarotid vascular access for TAVR is safe and feasible and is associated with encouraging short-term clinical outcomes. Our data suggest a clinical benefit of transcarotid TAVR with respect to atrial fibrillation, major bleeding, acute kidney injury, and length of stay compared with the more invasive transapical or transaortic strategies. Randomized studies are required to ascertain whether transcarotid TAVR yields equivalent results to other alternative vascular access routes.

1 February 2011 in Current Cardiology Reviews
Verified
Journal Article
Open access
RARamzi Abi-Akar
Ramzi Abi-Akar
IRIssam El Rassi
Issam El Rassi
NKNicole Karam
Nicole Karam
YJYehya Jassar
Yehya Jassar
RSRita Slim
Rita Slim
VJVictor Jebara
Victor Jebara
Abstract: Heyde's syndrome is the association between calcific aortic stenosis and gastrointestinal bleeding due to angiodysplasia. Alterations in von Willebrand factor due to turbulence across the diseased aortic valve have been incriminated in the pathophysiology of this syndrome. Replacement of the aortic valve has been reported to stop the bleeding, but this is debatable. Along with a review of the relevant medical literature, we hereby report a 68 year old patient with aortic stenosis and severe recurrent gastrointestinal bleeding that completely subsided following aortic valve replacement.

23 December 2021 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
AAAlberto Alperi
Alberto Alperi
AMAngela McInerney
Angela McInerney
TMThomas Modine
Thomas Modine
CCChekrallah Chamandi
Chekrallah Chamandi
JTJose D Tafur-Soto
Jose D Tafur-Soto
JRJosep Rodés-Cabau
Josep Rodés-Cabau
Obesity may increase the risk of vascular complications in transfemoral (TF) transcatheter aortic valve replacement (TAVR) procedures. The transcarotid (TC) approach has recently emerged as an alternative access in TAVR. We sought to compare vascular complications and early clinical outcomes in obese patients undergoing TAVR either by TF or TC vascular access. Multicentre registry including obese patients undergoing TF- or TC-TAVR in 15 tertiary centres. All patients received newer-generation transcatheter heart valves. For patients exhibiting unfavourable ileo-femoral anatomic characteristics, the TC approach was favoured in 3 centres with experience with it. A propensity score analysis was performed for overcoming unbalanced baseline covariates. The primary end point was the occurrence of in-hospital vascular complications (Valve Academic Research Consortium-2 criteria). A total of 539 patients were included, 454 (84.2%) and 85 (15.8%) had a TF and TC access, respectively. In the propensity-adjusted cohort (TF: 442 patients; TC: 85 patients), both baseline and procedural valve-related characteristics were well-balanced between groups. A significant decrease in vascular complications was observed in the TC group (3.5% vs 12% in the TF group, odds ratio: 0.26, 95% CI: 0.07–0.95, P = 0.037). There were no statistically significant differences between groups regarding in-hospital mortality (TC: 2.8%, TF: 1.5%), stroke (TC: 1.2%, TF: 0.4%) and life-threatening/major bleeding events (TC: 2.8%, TF: 3.8%). In patients with obesity undergoing TAVR with newer-generation devices, the TC access was associated with a lower rate of vascular complications. Larger randomized studies are warranted to further assess the better approach for TAVR in obese patients.

1 May 2019 in Archives of Cardiovascular Diseases
Verified
Journal Article
Closed access
RARamzi Abi Akar
Ramzi Abi Akar
NTNoémie Tence
Noémie Tence
JJJérome Jouan
Jérome Jouan
WBWassim Borik
Wassim Borik
PMPhilippe Menasché
Philippe Menasché
PAPaul Achouh
Paul Achouh

1 November 2013 in Circulation: Heart Failure
Verified
Journal Article
Closed access
PDF file
NBNadia Bouabdallaoui
Nadia Bouabdallaoui
RARamzi Abi Akar
Ramzi Abi Akar
PEPierre Vladimir Ennezat
Pierre Vladimir Ennezat
NANadia Aissaoui
Nadia Aissaoui
JJJerome Jouan
Jerome Jouan
JGJean Michel Grinda
Jean Michel Grinda